May 8, 2023 – In March 2022, Chris Holt joined SoftWave TRT as a strategic advisor and co-CEO, bolstering the company’s growth and clinical effectiveness across various healthcare sectors. Prior to his strategic advisory work and his tenure at SoftWave TRT, Holt held the position of Leader, Global Healthcare at Amazon, where he played a pivotal role in establishing Amazon Business for healthcare, and was instrumental in developing initiatives across Cloud/ML/AI, Pharmacy, and Medical domains.
Previously, Holt served as the Senior Vice President of Business Ventures at Vizient, managing hospital-facing supply networks with non-profit hospital expenditures surpassing $10 billion. His diverse experience also includes roles as CEO of Tiger Medical, leading China operations for Cardinal Health, and guiding UPS Healthcare’s early expansion.
SoftWave TRT, LLC, a leading medical technology company, specializes in Extracorporeal Shockwave Therapy (ESWT) utilizing unfocused, electrohydraulic shockwaves. The patented, non-invasive treatment has been proven to be effective and safe offering quick treatment times and faster healing for orthopedics, pain, wound care, urology, traumatology, and aesthetics. SoftWave TRT has doubled in size in the past year, and is dedicated to advancing the science of tissue healing and regeneration, as well as developing cutting-edge solutions that enhance the quality of life for people around the world.
Holt is a well-known, disruptive innovator in healthcare, having designed and scaled several new businesses that continue as billion dollar plus forces today. He is a passionate advocate for a smarter, simpler, more affordable healthcare system, where consumers can control their destiny and take charge of their health.